Hunt Ronald's Form 4 filing
Harpoon Therapeutics, Inc. (HARP) · filed Aug 12, 2021
- Accession no.
- 0000899243-21-032747
- Filed
- Aug 12, 2021
- Trade date
- Jan 11, 2021
- Filing delay
- 213 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $4.00M. It was filed 213 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hunt RonaldCIK 0001247851 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2021 | Common Stock | PPurchaseAcquired | +235,294 | $17.00 | +$3,999,998 | 913,860 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.